Sarepta Therapeutics is one of the firms working on gene therapy and has enough evidence on hand for the potential treatment of Duchenne muscular dystrophy. The firm claims that it has enough clinical data that shows their treatment is safe and effective to treat muscle-wasting disorder. Though an important Phase 3 trial is still underway and may yield data the coming year, the firm is interacting with regulators for submission under approval pathways.
Read More from MedcityNews
According to Business Wire, global Healthcare Industry will be worth $12T by 2022. Healthcare is vast and highly fragmented with a mix of public and private players. It comprises patients and healthcare providers such as hospitals, pharmaceuticals, and related life sciences.
Digitisation and Post-Covid world are set to transform the healthcare industry in the coming decade. Our weekly business newsletter covers innovations and disruptions in the Healthcare industry with global coverage.
HealthGeniuses is managed by IndustryGeniuses (A place where industries meet innovation). We are rolling out content platforms for the world’s hottest industries such as Food & Grocery Retail, Consumer Goods and Healthcare. For each of these key industries, we support Tech Startups and Industry Disruptors as they roll out next generation digital initiatives.
IndustryGeniuses team brings practical domain knowledge of working with 300+ tech startups and brands over the past decade.